Organicell appoints Howard Golub as EVP/CSO; 30+ years in clinical therapeutics

Zeo ScientifiX, Inc.

Howard L. Golub, MD, PhD appointed EVP and Chief Science Officer effective June 29, 2023.
Dr. Golub brings over 30 years of clinical research experience, including VP R&D at Walgreens Boots Alliance and founding CareStat LLC.
He will lead Organicell's R&D for innovative regenerative biologic therapies.
CEO Harry Leider stated the appointment strengthens the company's research leadership.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.